BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 94043)

  • 21. Estrogen receptor: a valid test for selection of breast cancer patients for endocrine ablation.
    Leung BS; Fletcher WS; Krippaehne WW
    Surg Forum; 1973; 24():125-7. PubMed ID: 4142813
    [No Abstract]   [Full Text] [Related]  

  • 22. Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer.
    Mercier O; Fadel E; de Perrot M; Mussot S; Stella F; Chapelier A; Dartevelle P
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):136-40. PubMed ID: 15999053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of adrenalectomy and androgen in disseminated mammary carcinoma.
    Dao TL; Nemoto T
    Surg Gynecol Obstet; 1965 Dec; 121(6):1257-62. PubMed ID: 4158865
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylactic oophorectomy in operable instances of carcinoma of the breast.
    Bryant AJ; Weir JA
    Surg Gynecol Obstet; 1981 Nov; 153(5):660-4. PubMed ID: 7292264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precise selection of breast cancer patients with bone metastasis for endocrine ablation.
    Minton JP
    Surgery; 1976 Oct; 80(4):513-7. PubMed ID: 184557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral adrenalectomy for advanced female breast cancer.
    Wawro NW; Mukerji MJ; Deren M
    Conn Med; 1977 Feb; 41(2):67-70. PubMed ID: 837674
    [No Abstract]   [Full Text] [Related]  

  • 28. Technique of adrenalectomy for metastatic cancer of the breast.
    Pressman PI
    Surg Gynecol Obstet; 1976 May; 142(5):743-7. PubMed ID: 178060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
    Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
    BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
    Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
    Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenalectomy for advanced breast cancer: a reappraisal.
    Paterson AG; Webster DJ
    Anticancer Res; 1983; 3(2):151-3. PubMed ID: 6189446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen and oophorectomy in the treatment of recurrent breast cancer: a Southwest Oncology Group Study.
    Hoogstraten B; Fletcher WS; Gad-el-Mawla N; Maloney T; Altman SJ; Vaughn CB; Foulkes MA
    Cancer Res; 1982 Nov; 42(11):4788-91. PubMed ID: 7127314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endocrine therapy of recurrent breast cancer].
    Nomura Y; Tashiro H
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):421-7. PubMed ID: 3890756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast.
    Fracchia AA; Farrow JH; Miller TR; Tollefsen RH; Greenberg EJ; Knapper WH
    Surg Gynecol Obstet; 1971 Aug; 133(2):241-6. PubMed ID: 4105232
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of positron emission tomography in selecting patients with metastatic cancer for adrenalectomy.
    Harrison J; Ali A; Bonomi P; Prinz R
    Am Surg; 2000 May; 66(5):432-6; discussion 436-7. PubMed ID: 10824742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limits of palliative surgery in cancer.
    Pettavel J
    Aktuelle Probl Chir; 1970; 14():709-24. PubMed ID: 4124390
    [No Abstract]   [Full Text] [Related]  

  • 37. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
    Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E
    Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of estrogen receptor to endocrine ablation in cancer of the breast.
    Leung BS; Krippaehne WW; Fletcher WS
    Surg Gynecol Obstet; 1974 Oct; 139(4):525-8. PubMed ID: 4138654
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surgical strategy in the treatment of adrenal cortex cancer. Expanded and repeated interventions].
    Borrelli D; Bergamini C; Borrelli A; Reddavide S; Lassig R; Valeri A
    Ann Ital Chir; 2003; 74(3):311-7. PubMed ID: 14677288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
    Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
    Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.